Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Neoplasm Metastasis 1Melanoma 1

Interventions

pembrolizumab 1269Specimen Handling 870Carboplatin 830Magnetic Resonance Spectroscopy 808Cyclophosphamide 804Cisplatin 726Nivolumab 661Paclitaxel 634Gemcitabine 574Radiotherapy 570Biopsy 528Bevacizumab 472Dexamethasone 442fludarabine 408Docetaxel 378venetoclax 369Oxaliplatin 366Capecitabine 358Fluorouracil 356atezolizumab 338durvalumab 334Rituximab 331Doxorubicin 316Pemetrexed 305Radiosurgery 305Drug Therapy 301Ipilimumab 297Standard of Care 293Etoposide 284Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × omaveloxolone × 1 year × Clear all
NCT02259231 2025-06-04

RTA 408 Capsules in Patients With Melanoma - REVEAL

Biogen

Phase 1/2 Completed
41 enrolled 15 charts
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡